Josef Jost

597 total citations
13 papers, 473 citations indexed

About

Josef Jost is a scholar working on Infectious Diseases, Virology and Hepatology. According to data from OpenAlex, Josef Jost has authored 13 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 6 papers in Virology and 4 papers in Hepatology. Recurrent topics in Josef Jost's work include HIV/AIDS Research and Interventions (8 papers), HIV Research and Treatment (6 papers) and HIV/AIDS drug development and treatment (6 papers). Josef Jost is often cited by papers focused on HIV/AIDS Research and Interventions (8 papers), HIV Research and Treatment (6 papers) and HIV/AIDS drug development and treatment (6 papers). Josef Jost collaborates with scholars based in Switzerland, France and United Kingdom. Josef Jost's co-authors include Helen Kovari, Bruno Ledergerber, Markus Flepp, Rainer Weber, Darius Moradpour, Jacques Izopet, Philippe Bürgisser, Alain Kenfak-Foguena, Laurent Kaiser and Katharine Darling and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Emerging infectious diseases.

In The Last Decade

Josef Jost

13 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Josef Jost Switzerland 9 280 277 140 105 44 13 473
Piedad Arazo Spain 10 313 1.1× 211 0.8× 160 1.1× 236 2.2× 58 1.3× 32 462
María Luisa Mateos Spain 12 190 0.7× 368 1.3× 37 0.3× 270 2.6× 8 0.2× 19 477
Cristina Gotta Italy 6 100 0.4× 98 0.4× 73 0.5× 148 1.4× 37 0.8× 13 271
D. Rey France 14 212 0.8× 255 0.9× 141 1.0× 295 2.8× 117 2.7× 30 550
Ana Lucía Rendón Spain 8 335 1.2× 102 0.4× 231 1.6× 178 1.7× 43 1.0× 10 431
Juan González Spain 7 223 0.8× 285 1.0× 63 0.5× 355 3.4× 61 1.4× 14 467
Clara FT Yoshida Brazil 13 174 0.6× 445 1.6× 16 0.1× 364 3.5× 16 0.4× 15 510
Alessandro Chiodera Italy 9 135 0.5× 86 0.3× 91 0.7× 108 1.0× 41 0.9× 14 260
Antonio Antela Spain 14 501 1.8× 136 0.5× 395 2.8× 191 1.8× 141 3.2× 19 641
Rikizo Taira Japan 9 134 0.5× 340 1.2× 26 0.2× 355 3.4× 7 0.2× 13 491

Countries citing papers authored by Josef Jost

Since Specialization
Citations

This map shows the geographic impact of Josef Jost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josef Jost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josef Jost more than expected).

Fields of papers citing papers by Josef Jost

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josef Jost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josef Jost. The network helps show where Josef Jost may publish in the future.

Co-authorship network of co-authors of Josef Jost

This figure shows the co-authorship network connecting the top 25 collaborators of Josef Jost. A scholar is included among the top collaborators of Josef Jost based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josef Jost. Josef Jost is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Kenfak-Foguena, Alain, F. Schöni-Affolter, Philippe Bürgisser, et al.. (2011). Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV, Switzerland. Emerging infectious diseases. 17(6). 1074–1078. 103 indexed citations
2.
Kenfak-Foguena, Alain, F. Schöni-Affolter, Philippe Bürgisser, et al.. (2011). Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV, Switzerland. Emerging infectious diseases. 17(6). 1074–1078. 108 indexed citations
3.
Kovari, Helen, Bruno Ledergerber, Markus Flepp, et al.. (2009). Association of Noncirrhotic Portal Hypertension in HIV‐Infected Persons and Antiretroviral Therapy with Didanosine: A Nested Case‐Control Study. Clinical Infectious Diseases. 49(4). 626–635. 84 indexed citations
4.
Katlama, Christine, B Clotet, Andreas Plettenberg, et al.. (2001). Intensification of stable background therapy with abacavir in antiretroviral therapy experienced patients: 48‐week data from a randomized, double‐blind trial. HIV Medicine. 2(1). 27–34. 11 indexed citations
5.
Pei, P., et al.. (2000). Waterbirth and the risk of HIV to Health Care Workers (HCW). Pflege. 13(3). 152–159. 2 indexed citations
6.
Katlama, Christine, Bonaventura Clotet, Andreas Plettenberg, et al.. (2000). The role of abacavir (ABC, 1592) in antiretroviral therapy-experienced patients: results from a randomized, double-blind, trial. AIDS. 14(7). 781–789. 49 indexed citations
7.
Joly, Véronique, Mauro Moroni, Ercole Concia, et al.. (2000). Delavirdine in Combination with Zidovudine in Treatment of Human Immunodeficiency Virus Type 1-Infected Patients: Evaluation of Efficacy and Emergence of Viral Resistance in a Randomized, Comparative Phase III Trial. Antimicrobial Agents and Chemotherapy. 44(11). 3155–3157. 11 indexed citations
8.
Paris, Daniel H., Bruno Ledergerber, Rainer Weber, et al.. (1999). Incidence and Predictors of Virologic Failure of Antiretroviral Triple-Drug Therapy in a Community-Based Cohort. AIDS Research and Human Retroviruses. 15(18). 1631–1638. 67 indexed citations
9.
Boucher, Charles A., Françoise Brun‐Vézinet, Véronique Joly, et al.. (1999). Efficacy and safety of combination therapy with delavirdine and zidovudine: a European/Australian phase II trial. International Journal of Antimicrobial Agents. 11(1). 13–21. 8 indexed citations
10.
Jost, Josef. (1998). [Post-exposure HIV prevention within and outside the hospital].. PubMed. 55(5). 289–94. 1 indexed citations
11.
Giezendanner, Stéphanie, et al.. (1994). [HIV infection, fever and cholestasis].. PubMed. 83(24). 757–60. 2 indexed citations
12.
13.
Jost, Josef, et al.. (1988). [HIV-associated thrombocytopenia].. PubMed. 118(6). 206–12. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Piedad Arazo Breakdown of academic impact, for papers by María Luisa Mateos Breakdown of academic impact, for papers by Cristina Gotta Breakdown of academic impact, for papers by D. Rey Breakdown of academic impact, for papers by Ana Lucía Rendón Breakdown of academic impact, for papers by Juan González Breakdown of academic impact, for papers by Clara FT Yoshida Breakdown of academic impact, for papers by Alessandro Chiodera Breakdown of academic impact, for papers by Antonio Antela Breakdown of academic impact, for papers by Rikizo Taira
Rankless by CCL
2026